N-Terminal amyloid-.beta. antibodies

   
   

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A.beta. in the brain of a patient Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred including N-terminal fragments of A.beta. and antibodies binding to the same.

 
Web www.patentalert.com

< Identification of sel-12 and uses thereof

< Tumor specific human monoclonal antibodies and methods of use

> Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R).

> Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies

~ 00129